MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
PSBD
Palmer Square Capital BDC Inc.
There isn't enough reported data to score PSBD yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
PSBD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
PSBD's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like PSBD.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
PSBD PE Valuation
PSBD has no meaningful PE right now: it lost money over the past year.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over PSBD on the outlook, with more favorable earnings and revenue expectations.
PSBD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect PSBD's earnings and profitability to decline, with its revenue holding steady.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the stronger earnings trend. Trailing diluted EPS is up 29% for MS versus PSBD down 7.9%.
PSBD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.54 | -12% |
| Q3 2023 | $3.42 | +$5.65 |
| Q2 2023 | $1.91 | +$3.78 |
| Q1 2023 | -$1.06 | -431% |
| Q4 2022 | -$2.31 | -485% |
PSBD earned $1.76 per share over the past year, down 7.9% from the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over PSBD in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
PSBD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2022 | $765.3K | -89% |
| Q3 2021 | $7.2M | -59% |
| Q2 2021 | $7.4M | -78% |
PSBD's revenue has slid since its 2020 peak: $765,339 last quarter, down 89% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2022 | -883% | -948 points |
| Q4 2021 | 54% | -33 points |
| Q3 2021 | 66% | -29 points |
| Q2 2021 | 68% | N/A |
| Q1 2021 | 69% | N/A |
| Q3 2020 | 87% | N/A |
| Q2 2020 | 95% | N/A |
PSBD's operating margin was −883% last quarter, down 952 points from the same quarter a year ago, near the bottom of its range since 2020.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
PSBD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $57.3M | +227% |
| Q2 2026 | $21.3M | -48% |
| Q1 2026 | $29.1M | -37% |
| Q4 2025 | $55.7M | +63% |
| Q3 2025 | $17.5M | +399% |
| Q2 2025 | $41M | +$41.5M |
| Q1 2025 | $46.4M | +$284.3M |
| Q4 2024 | $34.3M | +907% |
PSBD has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
PSBD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -461K shares |
| 1 year | -5.6% | -1.8M shares |
| 3 years | +24% | +5.9M shares |
| 5 years | -4.9% | -1.6M shares |
PSBD has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.2M |
| Q2 2026 | $4.1M |
| Q1 2026 | $1.6M |
| Q4 2025 | $7.6M |
| Q3 2025 | $4.7M |
| Q2 2025 | $4.2M |
| Q1 2025 | $1.5M |
| Q4 2024 | $765,047 |
PSBD spent $18M buying back its own shares over the past year, up 65% from the year before.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
PSBD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | 64.0x | High |
| Q4 2021 | 34.0x | High |
PSBD's net debt is more than 20 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like PSBD.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
PSBD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 33.0 | Neutral |
PSBD's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
PSBD PE vs Financial Services Sector
| Metric | PSBD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
PSBD has no meaningful PE right now: it lost money over the past year.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has stronger trend alignment. MS is above 3 of 5 weekly averages versus PSBD above 1 of 4.
PSBD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.78 | 0.5% above |
| 20 week MA | $10.0 | 1.8% below |
| 50 week MA | $10.7 | 7.8% below |
| 100 week MA | $12.3 | 20% below |
PSBD has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 20% below its 100-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over PSBD on returns for 2026, with the stronger performance.
PSBD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $16.4 | $15.5 | -5.3% |
| 2025 | $15.5 | $12.2 | -21% |
| 2026 YTD | $12.2 | $9.83 | -20% |
PSBD has finished every year since 2024 lower, and it's down 20% so far in 2026.